{
    "name": "Kava",
    "comment": "Herb/Suppl",
    "other_names": [
        "ava pepper",
        "awa",
        "intoxicating pepper",
        "kao",
        "kawa",
        "kew",
        "piper methysticum",
        "sakau",
        "tonga",
        "yagona"
    ],
    "classes": [
        "Neurology & Psychiatry",
        "Herbals"
    ],
    "source": "https://reference.medscape.com/drug/ava-pepper-awa-kava-344543",
    "pregnancy": {
        "common": [
            "Pregnancy Category: unsafe",
            "Lactation: unsafe"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: unsafe"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hepatitis, acute or hx"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Depression",
                "Risk of liver failure: banned in many countries (UK, Sweden, Netherlands etc)"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "amobarbital",
            "description": {
                "common": "kava increases effects of amobarbital by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "azelastine",
            "description": {
                "common": "kava increases effects of azelastine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "brompheniramine",
            "description": {
                "common": "kava increases effects of brompheniramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "butabarbital",
            "description": {
                "common": "kava increases effects of butabarbital by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "butalbital",
            "description": {
                "common": "kava increases effects of butalbital by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "carbinoxamine",
            "description": {
                "common": "kava increases effects of carbinoxamine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "chloral hydrate",
            "description": {
                "common": "kava increases effects of chloral hydrate by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "chlorpheniramine",
            "description": {
                "common": "kava increases effects of chlorpheniramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "cinnarizine",
            "description": {
                "common": "kava increases effects of cinnarizine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "clemastine",
            "description": {
                "common": "kava increases effects of clemastine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "clonazepam",
            "description": {
                "common": "kava and clonazepam both increase  sedation. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "cyclizine",
            "description": {
                "common": "kava increases effects of cyclizine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "cyproheptadine",
            "description": {
                "common": "kava increases effects of cyproheptadine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dexchlorpheniramine",
            "description": {
                "common": "kava increases effects of dexchlorpheniramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dexmedetomidine",
            "description": {
                "common": "kava increases effects of dexmedetomidine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dimenhydrinate",
            "description": {
                "common": "kava increases effects of dimenhydrinate by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "diphenhydramine",
            "description": {
                "common": "kava increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "doxylamine",
            "description": {
                "common": "kava increases effects of doxylamine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "hydroxyzine",
            "description": {
                "common": "kava increases effects of hydroxyzine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "pentobarbital",
            "description": {
                "common": "kava increases effects of pentobarbital by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "phenobarbital",
            "description": {
                "common": "kava increases effects of phenobarbital by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "primidone",
            "description": {
                "common": "kava increases effects of primidone by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "promethazine",
            "description": {
                "common": "kava increases effects of promethazine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "secobarbital",
            "description": {
                "common": "kava increases effects of secobarbital by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "triclofos",
            "description": {
                "common": "kava increases effects of triclofos by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "triprolidine",
            "description": {
                "common": "kava increases effects of triprolidine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "zidovudine",
            "description": {
                "common": "kava increases toxicity of zidovudine by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hepatoxicity."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Allergic skin reactions",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Drowsiness",
            "percent": null
        },
        {
            "name": "Enlarged pupils",
            "percent": null
        },
        {
            "name": "Gastrointestinal upset",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Hepatitis",
            "percent": null
        },
        {
            "name": "acute",
            "percent": null
        },
        {
            "name": "Hepatotoxicity",
            "percent": null
        },
        {
            "name": "Liver failure",
            "percent": null
        },
        {
            "name": "Motor reflex impairment",
            "percent": null
        },
        {
            "name": "Oculomotor equilibrium disturbances",
            "percent": null
        },
        {
            "name": "Parkinsonism",
            "percent": null
        },
        {
            "name": "Visual accommodation disturbances",
            "percent": null
        },
        {
            "name": "Body weight decreases",
            "percent": null
        },
        {
            "name": "chronic use",
            "percent": null
        },
        {
            "name": "Facial puffiness",
            "percent": null
        },
        {
            "name": "chronic use",
            "percent": null
        },
        {
            "name": "Hematuria",
            "percent": null
        },
        {
            "name": "chronic use",
            "percent": null
        },
        {
            "name": "Kava dermopathy",
            "percent": null
        },
        {
            "name": "chronic use",
            "percent": null
        },
        {
            "name": "Lymphocytopenia",
            "percent": null
        },
        {
            "name": "chronic use",
            "percent": null
        },
        {
            "name": "Movement disorders",
            "percent": null
        },
        {
            "name": "chronic use",
            "percent": null
        },
        {
            "name": "Protein levels decrease",
            "percent": null
        },
        {
            "name": "chronic use",
            "percent": null
        },
        {
            "name": "Pulmonary hypertension",
            "percent": null
        },
        {
            "name": "chronic use",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "chronic use",
            "percent": null
        },
        {
            "name": "Red blood cell volume increases",
            "percent": null
        },
        {
            "name": "chronic use",
            "percent": null
        },
        {
            "name": "Thrombocytopenia",
            "percent": null
        },
        {
            "name": "chronic use",
            "percent": null
        }
    ]
}